Paper · 993204
Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin.
Kitabgi P and 2 others. J Biol Chem, 1976. Cited by 201 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin. Papers, record 993204. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/993204
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intestine, Small | Major topic |
| Kinins | Major topic |
| Peptides | Major topic |
| Amino Acids | |
| Animals | |
| Biological Assay | |
| Blood Pressure | |
| Cattle | |
| Radioimmunoassay | |
| Rats |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,925,520 | Aptamers as target-specific recognition elements in drug delivery. | Adv Drug Deliv Rev | 2025 | https://conductscience.org/library/papers/40925520 | PubMed |
| 36,316,682 | The effect of a randomised controlled lifestyle intervention on weight loss and plasma proneurotensin. | BMC Endocr Disord | 2022 | https://conductscience.org/library/papers/36316682 | PubMed |
| 35,681,520 | Nucleic Acid Aptamers Emerging as Modulators of G-Protein-Coupled Receptors: Challenge to Difficult Cell Surface Proteins. | Cells | 2022 | https://conductscience.org/library/papers/35681520 | PubMed |
| 35,345,492 | Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35345492 | PubMed |
| 35,261,667 | Changes of Gastric Secretion after Bolus and Slow Intravenous Administration of Bombesin and Neurotensin. | Maedica (Bucur) | 2021 | https://conductscience.org/library/papers/35261667 | PubMed |
| 31,541,150 | The association between plasma proneurotensin and glucose regulation is modified by country of birth. | Sci Rep | 2019 | https://conductscience.org/library/papers/31541150 | PubMed |
| 31,489,118 | Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma. | Oncotarget | 2019 | https://conductscience.org/library/papers/31489118 | PubMed |
| 30,159,819 | Neurolysin: From Initial Detection to Latest Advances. | Neurochem Res | 2018 | https://conductscience.org/library/papers/30159819 | PubMed |
| 29,866,581 | Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study). | Am J Cardiol | 2018 | https://conductscience.org/library/papers/29866581 | PubMed |
| 27,312,221 | Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study. | Arterioscler Thromb Vasc Biol | 2016 | https://conductscience.org/library/papers/27312221 | PubMed |
1 to 10 of 35
See all 35 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/993204
GET https://conductscience.org/api/papers/v1/993204/cited_by?page=2